Sanofi Winthrop Industry Sanofi Winthrop Industry Sanofi-Aventis Ltd.
PolandAll medications by this manufacturer
-
Avaxim 160 iu
Form: solution for injection in ampoule-syringe
Active substance Dosage Hepatitis A virus GBM strain inactivated 160 antigenic units ATC: J07BC02
-
Imovax polio
Form: solution for injection in ampoule-syringe
Active substance Dosage Poliovirus type 1 Mahoney strain inactivated 29 units of antigen D Inactivated poliomyelitis vaccine 0.5 ml Poliovirus type 2 MEF-1 strain inactivated 7 units of antigen D Poliovirus type 3 Sabin strain inactivated 26 units of antigen D ATC: J07BF03
-
Tetraxim
Form: solution for injection in ampoule-syringe
Active substance Dosage diphtheria toxoid minimum 30 IU tetanus toxoid minimum 40 IU Bordetella pertussis antigens 25 micrograms poliovirus type 1 Mahoney strain inactivated 40 units of antigen D poliovirus type 2 MEF-1 strain inactivated 8 units of antigen D poliovirus type 3 Sabin strain inactivated 32 units of antigen D ATC: J07CA02
-
Typhim vi
Form: solution for injection in ampoule-syringe
Active substance Dosage Purified Vi capsular polysaccharide of Salmonella typhi (Ty2 strain) 25 mcg ATC: J07AP
-
Vaxigrip
Form: solution for injection in ampoule-syringe
Active substance Dosage A/Victoria/4897/2022 (H1N1)pdm09 influenza virus strain No input provided influenza A virus strain A/Croatia/10136RV/2023 (H3N2) No input provided influenza virus B/Austria/1359417/2021 strain No input provided ATC: J07BB02
-
Vaxigriptetra
Form: solution for injection in ampoule-syringe
Active substance Dosage inactivated split influenza virus containing strains A/Victoria/4897/2022 (H1N1)pdm09 A/Darwin/9/2021 (H3N2) B/Austria/1359417/2021 B/Phuket/3073/2013 No input provided ATC: J07BB02
-
Verorab
Form: powder and solvent for preparation of suspension for injection
Active substance Dosage Rabies virus Wistar Rabies PM/WI38 1503-3M inactivated not less than 2.5 IU Rabies virus Wistar Rabies PM/WI38 1503-3M inactivated No input provided ATC: J07BG01